Beta-Glucan Market Detailed Analysis With Leading Key Players

The beta-glucan market, in terms of value, is estimated to account for nearly USD 403.8 million in 2020 and is projected to grow at a CAGR of 7.6%, to reach nearly USD 628.3 million by 2026. With the shift in demand from processed to healthy food, functional, and superfoods, consumers have become more conscious of their health and maintain it proactively through healthy living. Consumers are more aware of the food ingredients and pay attention to nutrition labels and ingredients of the food products. This change in buying habits has resulted in higher demand for healthy foods and supplements and has attracted several manufacturers to offer new food products that are functional, not genetically modified, and sourced naturally forming one of the major factors that has boosted the demand for beta-glucan globally.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796

By category the soluble segment is expected to hold a higher share as compared to the insoluble segment

Soluble dietary fibers also reduce the total plasma cholesterol and lower the glycemic index of food providing numerous health benefits. Insoluble beta-glucan is found in larger amounts in cereal, such as brown rice. Wholemeal flour and bread, wholegrain breakfast cereals, brown rice, corn bran, and wholemeal pasta are all good sources. This type of fibrous beta-glucan is vital for a healthy digestive system further leading to the segment holding a significant share in the overall market for beta-glucan.

The yeast segment as a source is expected to hold one of the largest share in the beta-glucan market, in terms of value, in 2020

Baker's yeast grows aerobically and is dependent on sugar molasses, whereas brewer's yeast is not. Baker's yeast is estimated on the basis of consumption of baker's product while brewer's yeast depends on alcohol products. The immune-modulating abilities of the final product together with supportive research studies for the immune-modulating properties of baker's yeast has driven the demand for yeast beta-glucan globally.

By application pharmaceutical and food & beverage will be the key areas to drive the demand for beta-glucan, in terms of value, in 2020

Pharmaceutical products come in the form of capsules, liquid, powder, or tablets and are taken to balance the deficiencies of ingredients in diets and for curing problems, such as obesity, blood pressure, and diabetes. These products have been extensively studied for their immunological and pharmacological effects. Immunologically active, homogeneous, non-aggregated, and micro-particulate beta-glucan is prepared from saccharomyces cerevisiae which has resulted in growing applications across the industry. Moreover, the rising sedentary lifestyle and increased consumption of calorie-rich food, have caused numerous health problems, such as obesity, high blood pressure, high cholesterol, and heart attack. The intake of beta-glucan has helped in reducing the risk of these health problems with its health-promoting properties further driving the beta glucan applications.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=5191796

North America is projected to dominate the majority market share, in the global beta-glucan market, in terms of value, in 2020

The North American beta-glucan market is led by its broad applications in various products along with their health benefits. The key market players in the North American beta-glucan market include Cargill (U.S.), Millipore Sigma (U.S.), and Lesaffre (U.S.). Technological advancements have made beta-glucan available for a wide range of applications in the food & beverage sector in the form of thickening agents, fat substitutes, dietary fiber, and hypocholesterolemia agents; these are likely to drive the growth in the region.

Leading companies are Cargill Inc (US), Tate & Lyle Plc (UK), Kerry Group Plc (Ireland), Koninklijke DSM N.V. (Netherlands), Frutarom (Israel), Garuda International Inc (US), Ohly GmbH (Germany), Milliporesigma (US), Super Beta Glucan (US), Lesaffre Human Care (France), Kemin Industries (US), Angel Yeast Co Ltd (China), Biotec BetaGlucans AS (Norway), AIT Ingredients (France), Biorigin Zilor (Brazil), Ceapro Inc (Canada), Specialty Biotech Co Ltd (Thailand), and Alltech Life Sciences (US) among others.

Read more: https://www.marketsandmarkets.com/Market-Reports/beta-glucan-market-5191796.html

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.